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Use of Quantitative Membrane Proteomics Identifies a Novel
Role of Mitochondria in Healing Injured Muscles*□S
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Nimisha Sharma‡1, SushmaMedikayala‡, Aurelia Defour‡, Sree Rayavarapu‡§, Kristy J. Brown‡, Yetrib Hathout‡,
and Jyoti K. Jaiswal‡¶2
From the ‡Center for Genetic Medicine Research, Children’s National Medical Center, Washington D. C. 20010 and the §Institute of
Biomedical Sciences and ¶Department of Integrative Systems Biology, GeorgeWashington University, Washington, D. C. 20010
Background: Cellular processes involved in healing injured skeletal muscle fibers are poorly understood.
Results:Using an improved quantitativemembrane proteomics approach for cells and tissues, we have identified accumulation
of mitochondria at the site of sarcolemma injury as a key requirement for myofiber healing.
Conclusion:Mitochondria are the earliest responders to myofiber injury.
Significance: This work identifies a novel function of mitochondria in muscle injury.
Skeletal muscles are proficient at healing from a variety of
injuries. Healing occurs in two phases, early and late phase.
Early phase involves healing the injured sarcolemma and
restricting the spread of damage to the injured myofiber. Late
phase of healing occurs a few days postinjury and involves inter-
action of injuredmyofibers with regenerative and inflammatory
cells. Of the two phases, cellular and molecular processes
involved in the early phase of healing are poorly understood.We
have implemented an improved sarcolemmal proteomics
approach together with in vivo labeling of proteins with modi-
fied amino acids inmice to study acute changes in the sarcolem-
mal proteome in early phase of myofiber injury. We find that a
notable early phase response to muscle injury is an increased
association ofmitochondria with the injured sarcolemma. Real-
time imaging of live myofibers during injury demonstrated that
the increased association of mitochondria with the injured sar-
colemma involves translocation of mitochondria to the site of
injury, a response that is lacking in cultured myoblasts. Inhibit-
ing mitochondrial function at the time of injury inhibited heal-
ing of the injuredmyofibers. This identifies a novel role ofmito-
chondria in the early phase of healing injured myofibers.
Skeletal muscles routinely undergo mechanical injury fol-
lowed by full healing. The healing often further enhances the
muscle function. In the early phase of healing, the injured sar-
colemma is repaired, and the injury to themyofiber is contained
by the formation of a stump that prevents the rest of the myo-
fiber from becoming necrotic (1–3). This is followed by a late
phase of healing where the stump and necrotic tissue are
cleared by inflammatory cells, the myogenic cells are activated
to fuse with the myofibers, and the damagedmuscle is regener-
ated (4, 5). In the early phase, trafficking of proteins and lipids to
the injured sarcolemma augments healing of the injured myo-
fiber. In the late phase, trafficking across sarcolemma helps in
cell-cell and cell-matrix signaling (1, 6–8). Thus, monitoring
dynamic changes in the sarcolemmal proteome would improve
our understanding of how these two phases are regulated and
help to better understand various neuromuscular disorders
associated with defects in myofiber degeneration and regener-
ation (6, 9). Such changes have been studied during the late
phase of healing; however, little is known about such changes
during the early phase of myofiber healing (2, 3, 7, 8).
There are several studies that have analyzed the whole pro-
teome of themuscle tissue and culturedmuscle cells (10–16). A
few studies have also analyzed the membrane proteins present
in the sarcolemma (17–21). These latter studies did not capture
the proteome associated with the inner or outer leaflet of the
sarcolemmal proteome, which is key for sarcolemmal function
and is the target ofmutations leading tomanymuscular dystro-
phies (6). Commonly used methods for isolation of cell mem-
brane proteome are based on subcellular fractionation and
result in preparations containing abundant cytosolic proteins
(18, 22–24). At least three different affinity-based enrichment
strategies have been developed to increase the purity and yield
of cell membrane proteome (22). One approach uses biotin to
selectively tag cell surface proteins followed by the use of
streptavidin beads to pull down the tagged proteins (25, 26).
Another approach relies on the assumption that themajority of
membrane proteins are glycosylated, and lectin (27) or hydra-
zide chemistry (28) is used to tag these proteins. Yet another
approach has exploited the electrostatic interaction between
cationic colloidal silica and anionicmembrane lipids on the cell
surface to increase the stability and density of the plasmamem-
brane and, subsequently, to separate it using centrifugation
(29). These approaches for isolating sarcolemmal proteome
frommuscles rely on the use of a large amount of tissue (17, 19,
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20, 20, 21). Thus, they are notwell suited for studying the effects
of focalmuscle injuries or studying smallermuscles. In addition
to approaches to enrich cell membrane proteins, the use of
proteome-wide monitoring of small changes in the level of sar-
colemmal proteins requires increased sensitivity in detecting
these changes. Mass spectrometry (MS) is a technique well
suited for large scale monitoring of changes in protein levels,
and isotopic labeling of proteins has emerged as an efficient
approach for MS-based detection of small changes in protein
levels (30). Isotopic labeling has been carried out using different
techniques, including iTRAQ (isobaric tags for relative and
absolute quantitation), ICAT (isotope-coded affinity tags), and
stable isotope labeling of amino acids in culture (SILAC)3 (30,
31). The SILAC approach has also been extended to detect dif-
ferential protein expression in animal tissues by feeding ani-
mals formultiple generations a diet containing amino acids that
have a stable isotope of carbon, 13C6 (30, 32, 33).
In the present study, we have combined features of the exist-
ing proteomic approaches to develop a unified method for
improved recovery of sarcolemmal proteins from mononu-
cleate andmultinucleatemyocytes. This involves biotin tagging
of sarcolemmal proteins followed by affinity-based enrichment
of sarcolemmal fragments containing biotinylated and other
proteins tightly associated with the sarcolemma. Using this
rapid two-step procedure, we isolated the sarcolemma and
associated proteome from muscle cells in culture (C2C12 and
immortalized mouse primary myoblasts) and from myofibers
isolated from mouse muscle tissue. This approach provided
improved sensitivity of detection of sarcolemmal proteins, even
from small muscle samples. We applied this approach in com-
bination with stable isotope labeling of proteins in mice and
studied changes in the sarcolemmal proteome during the early
phase of myofiber injury. We found an increased association of
active mitochondria with the injured sarcolemma within sec-
onds of myofiber injury. This response involved accumulation
of mitochondria at the site of myofiber injury but is lacking in
culturedmuscle cells. This identified an unrecognized response
of mitochondria to muscle injury and demonstrates the utility
of our proteomic approach for studying even small and acute
changes in sarcolemmal proteome.
EXPERIMENTAL PROCEDURES
Cell Culture—C2C12 myoblast cell line was maintained in
Dulbecco’s modified Eagle’s medium (DMEM) with Glutamax,
high glucose, 110 mg/liter sodium pyruvate (Invitrogen) sup-
plemented with 10% fetal bovine serum (Hyclone, Thermo
Fisher Scientific) and with 100 g/ml penicillin and 100 g/ml
streptomycin (Invitrogen). H2K myoblasts were cultured in
DMEM supplemented with 20% fetal bovine serum (Hyclone),
2% chicken embryo extract (Accurate Chemical, Westbury,
NY), and 100 g/ml each of penicillin and streptomycin (Invit-
rogen). Prior to culturing H2K cells, 10 g of -interferon
(RocheApplied Science) was added to 500ml of the constituted
media, and culture dishes were coated with 0.1% gelatin at
room temperature for 30 min.
Animal Husbandry, Generation of Stable Isotope Labeling in
Mammals (SILAM) Mouse, and Myofiber Isolation—Methods
involving animals were approved by the local Institutional Ani-
mal Research Committee, and animals were maintained in a
facility accredited by the American Association for Accredita-
tion of Laboratory Animal Care. Lysine (13C6)-labeled C57BL6
mice were developed by feeding a custom diet containing
“heavy” (13C6) lysine at 1% level that adheres to the regular
laboratory mouse nutritional standards (mouse feed pellets
L-lysine (13C6, 99%); Cambridge Isotope Laboratories, Andover,
MA). Briefly, C57BL6 breeding pairs were obtained and housed
in an individually vented cage system under a controlled 12-h
light/dark cycle with free access to feed and water. The preg-
nant mother was fed with a customized heavy lysine diet until
the litter (F1 generation) was weaned. After weaning, the pups
were continued on a heavy lysine diet and bred to obtain the
next litter (F2 generation). Incorporation of (13C6) lysine in tis-
sue proteins was monitored using mass spectrometry in the
mother and in each generation. Results demonstrated an
improvement in labeling efficiency in the tissues in each gener-
ation upon continuous feeding with the heavy lysine diet. By F2
generation, the incorporation efficiency of heavy lysine was
98–100% average labeling efficacy of all uniquely identified
proteins for the different tissues tested, including skeletal mus-
cle, brain, and liver. The labeling efficacy for skeletal muscles
was 98.26 3.5% (supplemental Fig. 1). Incorporation efficien-
cies we obtained are similar to those described earlier (34).
Prior to harvesting the muscle tissue, mice were perfused with
PBS and then euthanized with carbon dioxide asphyxiation.
The desired muscles (EDL, soleus, and tibialis anterior) were
carefully dissected while handling the tissue by tendons only
and avoiding stretching or touching the muscle fibers. Muscle
tissues were removed immediately, weighed, and processed for
subcellular fractionation and sarcolemmal protein extraction
as described below. For myofiber isolation, a sterile solution of
collagenase type 1 (2 mg/ml in DMEM; Sigma-Aldrich) was
prepared immediately before tissue extraction. The extracted
muscles were placed into individual vials of collagenase and
incubated in a 35 °C shaking water bath for 1–2 h depending on
the size of the muscle. The fibers were then liberated by gentle
trituration with a fire-polished wide-mouthed Pasteur pipette
that had been rinsed in DMEM containing 10% horse se-
rum. The medium was removed carefully, and the fibers were
washed three times with DMEM. The fibers were then used for
biotinylation and membrane sheet preparation as described
below. For injury, the biotinylated myofibers were passed
through a narrow-mouthed Pasteur pipette, resulting in10%
hypercontracted fibers.
Cell Surface Biotinylation—C2C12, H2K myoblasts, or mus-
cle fibers were washed three times with cold Hanks’ balanced
salt solution (HBSS; Sigma-Aldrich) and treatedwith 0.5mg/ml
EZ-Link Sulfo-NHS-LC-Biotin (Thermo Fisher Scientific)
made in cold HBSS (pH 7.4). The cells or fibers were incubated
for 30min at 4 °C, followed by a singlewashwith coldHBSS and
3 The abbreviations used are: SILAC, stable isotope labeling of amino acids in
culture; SILAM, stable isotope labeling in mammals; EDL, extensor digitorum
longus; HBSS, Hanks’ balanced salt solution; Sulfo-NHS-LC-Biotin, sulfosuccin-
imidyl-6-[biotin-amido]hexanoate; RIPA, radioimmune precipitation assay;
GO, Gene Ontology; CCCP, carbonyl cyanidem-chlorophenylhydrazone; Bis-
Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
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then incubated with cold 0.1 M Tris-HCl solution, pH 7.4, at
4 °C for 10–15 min to quench unreacted biotin.
Isolation of Sarcolemmal Proteome by Detergent-based
Solubilization—Cell surface proteins of C2C12 cells grown in
one cell culture dish (15-cm diameter) were biotinylated using
EZ-Link Sulfo-NHS-LC-Biotin (Thermo Fisher Scientific) in
HBSS. Biotinylated cells were lysed at room temperature with 1
ml of cold RIPA buffer (Sigma-Aldrich) containing protease
inhibitors (Thermo Fisher Scientific). Cell lysates were har-
vested using a cell scraper and centrifuged at 13,000 rpm for 5
min at 4 °C. The supernatant was transferred to a fresh tube,
and the total amount of protein was estimated using the Bio-
RadDCprotein assay kit (Bio-Rad). Up to 800g of proteinwas
incubated for 1 h with 200l of DynabeadsMyOneTM Strepta-
vidin C1 magnetic beads (Invitrogen) pre-equilibrated with
RIPA buffer (Sigma-Aldrich). The beads were collected using
the Dynamag-2 magnet (Invitrogen). To remove weakly/non-
specifically bound cytosolic proteins, the beads were washed
once with cold RIPA buffer, followed by high salt and high pH
washes. For the high salt wash, buffer containing 50 mM Tris-
HCl, pH 8.0, and 150 mM NaCl was used for 10 min. For high
pH, two washes (5 and 30 min each) with cold 100 mM sodium
carbonate solution, pH 11.5, were given. All salts were subse-
quently removed by two washes with water. All washes were
done at 4 °C in the presence of protease inhibitors (Thermo
Fisher Scientific).
Isolation of Sarcolemmal Proteome by Cell Rupture and
Membrane Sheet Preparation—C2C12 myoblasts were grown
in one or two cell culture dishes (15-cm diameter), and H2K
myoblasts were grown in three 15-cm dishes. Subsequently,
cultured cells or muscle fibers were treated with biotin as
described above. Biotinylated cells or fibers were washed once
with cold HBSS. Subsequently, 2 ml of ice-cold HBSS contain-
ing protease inhibitors was added to each 15-cm dish, and the
cells were collected using a cell scraper. The cell suspensionwas
homogenized with 50 strokes in a tight fitting 2-ml Dounce
homogenizer using pestle B (Corning Inc.). Lysiswas confirmed
microscopically, and the homogenate was centrifuged at low
speed (800 g, 10min, 4 °C) to remove intact nuclei. The post-
nuclear supernatant was removed, and the protein concentra-
tion was estimated using the Bio-Rad DC protein assay kit
(Bio-Rad). The postnuclear supernatantwas then bound to pre-
equilibrated streptavidin beads and processed as above, except
that the streptavidin beads were not given the first wash with
RIPA buffer.
Sample Preparation, In-gel Digestion, and Peptide Extraction—
The streptavidin beads containing bound biotinylated plasma
membrane proteins were rinsed twice with cold water and
resuspended in 2 SDS sample buffer containing 2.5% -mer-
captoethanol. The sample was heated at 50 °C for 30 min to
elute the proteins bound to the beads, followed by one-dimen-
sional SDS-PAGE using a precast 4–12% gel (BisTris Novex
minigel, Invitrogen). The gel was fixed with methanol/water/
acetic acid (45:50:5, v/v/v) for 30 min, and subsequently bands
were visualized by staining with Bio-Safe Coomassie Blue (Bio-
Rad). The fractionated gel lane was excised into 35 bands. Each
slice was destained with 50% acetonitrile (v/v) and 100 mM
NH4HCO3, dehydrated with 100% acetonitrile. Gel pieces were
rehydrated in 10–20 l of cold digestion buffer (12.5 ng/l of
sequencing grade trypsin (Promega) in 50 mM NH4HCO3) and
incubated at 4 °C for 45 min. The excess buffer was removed
and replaced with 5 l of 50 mM NH4HCO3. Digestion with
trypsin was carried out overnight at 37 °C. Tryptic peptides
were extracted with 50% acetonitrile with 5% formic acid,
repeated twice. Pooled peptides were dried by vacuum centrif-
ugation and resuspended in 10 l of 0.1% trifluoroacetic acid.
LC-MS/MS—All analyses were carried out on a hybrid
ThermoLTQ-Orbitrap-XLmass spectrometer (ThermoFisher
Scientific) coupled online to a nano-LC system (Eksigent, Dub-
lin CA). The concentrated peptides from each band were
injected via an autosampler (6 l) and loaded onto a Symmetry
C18 trap column (5 m, 300-m inner diameter  23 mm,
Waters) for 10 min at a flow rate of 10 l of 0.1% formic acid/
min. The sample was subsequently separated by a C18 reverse-
phase column (3.5m, 75m 15 cm,Dionex) at a flow rate of
250 nl/min. The mobile phases consisted of water with 0.1%
formic acid (A) and 90% acetonitrile (B). A 65-min linear gra-
dient from 5 to 60% B was employed. Eluted peptides were
introduced into themass spectrometer via a 20-minner diam-
eter, 10-m silica tip (New Objective Inc., Woburn, MA)
adapted to a nanoelectrospray source (Thermo Fisher Scien-
tific). The spray voltage was set at 1.4 kV, and the heated capil-
lary was set at 200 °C. The LTQ-Orbitrap-XL mass spectrome-
ter was operated in data-dependent mode with dynamic
exclusion in which one cycle of experiments consisted of a full
MS in the Orbitrap (300–2000m/z) survey scan (profile mode
for SILAM and centroid for label-free), 30,000 resolution, and
five subsequent MS/MS scans in the LTQ of the most intense
peaks in centroid mode using collision-induced dissociation
with the collision gas (helium) and normalized collision energy
value set at 35%.
Database Search and Analysis—Proteins were identified
from raw MS and MS/MS data using the Sequest algorithm in
Bioworks Browser version 3.3.1 software (Thermo Fisher Sci-
entific) against the Uniprot mouse database (UniProt release-
2010_11, 16,333 entries) indexed for fully tryptic, 300–4000
mass range, and twomissed cleavages.Mass tolerancewas set at
50-ppm error for MS and 1-Da error for MS/MS and potential
modification of oxidized methionine (15.99492 Da). Protein
identifications were filtered as follows: CN  0.1; XCorr 
1.9, 2.2, 2.5, and 3.5 for z  1, 2, 3, and 4, respectively; two
distinct peptides; and peptide probability of 1  103. For
protein identification and quantification of SILAM samples, we
used Integrated Proteomics Pipeline (IP2) version 1.01 software
developed by Integrated Proteomics Applications, Inc. (San
Diego, CA)Mass spectral data were converted toMS1 andMS2
files using RawExtract version 1.9.1.1 and uploaded into IP2
software. Files from each lane were searched against the for-
ward and reverse Uniprot mouse database (UniProt release-
2010_11, 16,333 entries) for tryptic peptides allowing one
missed cleavage and possible modification of oxidized methio-
nine (15.99492 Da) and heavy lysine (6.0204 Da). IP2 uses the
Sequest 2010 (06_10_13_1836) search engine. Mass tolerance
was set at 30 ppm for MS and 1.5 Da for MS/MS. Data
were filtered based on a global 3% false discovery rate and at
least one peptide per protein at a 0.1% false discovery rate. All of
ANovel Role of Mitochondria inMuscle Injury
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the bands from each lane were summed in the analysis. Census
software version 1.77, built into the IP2 platform, was used to
determine the ratios of unlabeled and labeled peptide pairs using
an extracted chromatogram approach. The distribution of ratios
was corrected for error in sample mixing. Data were checked for
validity by using regression correlation better than 0.98 for each
peptide pair. A one-sample t test was performed to identify pro-
teins that were significantly (p 0.05) different from a value of 1
(no change); these were retained for further analysis.
Bioinformatics Analysis—The molecular mass values and
percentage of the protein covered by the matched peptides
were retrieved from Bioworks output files. The subcellular
location of each identified protein was determined using the
Gene Ontology (GO) and keyword information available from
the UniProt Knowledgebase (UniProt release 2011_08-Jul 27,
2011). The list was subsequently curated based on a review of
the published literature to assign unique localization for each
protein.
Live Imaging of Myofiber and Myotube Injury—For imaging
mitochondrial dynamics and healing of injured myofibers, live
myoblasts/myotubes or myofibers isolated from EDL and
soleus muscles as described above were used. The fibers were
plated on Matrigel-coated dishes in H2K myoblast cell culture
medium (described above) and maintained for 1–2 days in a
37 °C incubator with 5% CO2. For imaging mitochondria, live
fibers/cells were incubated for 15 min at 37 °C in 100 nMMito-
Tracker Red CM-H2XRos (Invitrogen). The excess dye was
washed off, and the fibers were transferred to cell imaging
medium (HBSS with 10 mM HEPES, pH 7.4) and imaged on an
inverted Olympus IX81 microscope (Olympus America) cus-
tom equipped with a CSUX1 spinning disc confocal unit (Yok-
ogawa Electric Corp., Tokyo, Japan), pulsed laser Ablate!TM
(Intelligent Imaging Innovations, Inc., Denver, CO), and diode
laser of 561 nm (Cobolt, Stockholm, Sweden). Images were
acquired using Evolve 512 EMCCD (Photometrics, Tucson,
AZ) at 1 Hz. Image acquisition and laser injury were controlled
using Slidebook 5.0 (Intelligent Imaging Innovations, Inc., Den-
ver, CO).
RESULTS
Isolation of Sarcolemmal Proteome Using theMembrane Sol-
ubilizationApproach—Use of biotin tagging of cell surface pro-
teins together with streptavidin beads has been used to pull
down cell surface proteins from cells and tissue (25, 26). Thus,
we used this approach to enrich plasma membrane proteins
from cultured myoblasts. Cell surface proteins were biotiny-
lated using Sulfo-NHS-LC-Biotin (biotin) and solubilized using
RIPAbuffer (35, 36), and the biotinylated proteinswere isolated
using streptavidin-conjugated agarose or magnetic beads, as
described under “Experimental Procedures.” Magnetic beads
allowed greater recovery of proteins as compared with agarose
beads (data not shown) and were used for all subsequent exper-
iments. To improve recovery of hydrophobic proteins and pep-
tides, isolated proteins were separated by SDS-PAGE, the gel
lane was cut into 30–35 bands, and proteins trapped in their
denatured state in the gel pieces were digested with trypsin
followed by LC-MS/MS analysis (Fig. 1). With these optimiza-
tions, we were able to identify a total of 544 unique proteins in
two combined biological replicate preparations (supplemental
Table S1). Based on GO annotations and published literature,
we determined that membrane proteins represented less than
one-third (29%) of these proteins, whereas cytosolic proteins
represented 41% of the total proteins (Fig. 2A).
Isolation of Sarcolemmal Proteome Using the Membrane
Sheet Approach—One possible reason for low enrichment of
membrane proteins could be that in manymembrane proteins,
primary amines are either not present or not exposed at the
extracellular face of the cell, making these proteins impervious
to labeling and pull-down using biotin and streptavidin. Thus,
to further enrich the sarcolemmal proteome, we utilized a dou-
ble enrichment approach. Following labeling of the cells with
biotin, instead of solubilizing with detergent, the cell mem-
brane was mechanically ruptured using a Dounce homoge-
nizer. The resulting cell membrane fragments contained not
only the biotinylated proteins but also other proteins that are
embedded in or tightly associated with the plasma membrane
sheet and are inaccessible to labeling by biotin (Fig. 1). As
depicted in Fig. 1, this approach will also enrich organelle pro-
teins that are associated with the sarcolemma such that high
salt and high pH buffer wash does not dissociate them from the
sarcolemmal membrane sheets. In general, this approach is
similar to affinity-based enrichment techniques used for the
isolation of plasma membrane proteins from non-muscle cells
(37–39). The plasma membrane sheets can then be separated
from other membranes by using streptavidin beads that will
bind the biotinylated proteins present only in the plasmamem-
brane sheets. Any non-specifically attached proteins can be
washed off of these sheets by sequentiallywashingwith high salt
and high pH buffers as described under “Experimental Proce-
dures.” Isolated proteins were resolved and analyzed by LC-
MS/MS as described above. We analyzed two biological repli-
cates and identified 579 unique proteins. Based on GO
annotation and published literature, the proportion of mem-
brane proteins obtained using the “membrane sheet” approach
increased to 53%. Furthermore, the proportion of nucleo-cyto-
plasmic proteins decreased by 2-fold compared with the deter-
gent solubilization approach at 20% (Fig. 2B and supplemental
Table S2).We evaluated the reproducibility of this approach by
four independent experiments, each of which resulted in a sim-
ilar percentage of proteins belonging to different subcellular
locations (Table 1).
Although C2C12 cells represent a useful myogenic cell line,
in view of the tumorigenic nature of these cells, we tested this
approach on mouse primary myoblast cell line (H2K) (40). We
identified a total of 964 unique proteins in two independent
experiments (supplemental Table S3). Of these, 53% of the pro-
teins were membrane proteins, and the rest exhibited a similar
distribution across the various subcellular locations as observed
in the C2C12 cells (Fig. 2C).
Isolation of the Cell Surface Proteome of Myofibers—Earlier
studies have used density gradient centrifugation to isolate sar-
colemma frommuscle (18, 22, 23). This requires a large amount
of muscle tissue and therefore is not suited for isolating sar-
colemmal proteins from smaller muscles or where changes are
limited to a part of the muscle tissue. Also, with existing
approaches, caution needs to be exercised when interpreting
ANovel Role of Mitochondria inMuscle Injury
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proteomic findings using total tissue extracts because homog-
enized muscle tissue contains proteins from other sources like
endothelial and blood cells. We tested the utility of our
approach in addressing the limitations of the existing ap-
proaches for isolating sarcolemmal proteome from muscle
fibers. To reduce the contribution of proteins from non-
muscle cells, we dissociated myofibers instead of using whole
muscle lysates (Fig. 3A). From two experiments where the EDL
and soleus myofibers were used together, the myofiber sarcolem-
mal proteome isolated using the membrane sheet enrichment
approach provided 451 unique proteins (supplemental Table
S4). Of these, subcellular locations were ascribed for 431 pro-
teins, and 33% of these proteins are membrane proteins (Fig.
3B). Similar results were obtained using the tibialis anterior
muscle (data not shown). The sarcolemma-associated proteins
isolated included integral and peripheral sarcolemmal proteins
implicated in healing of injured cells and myofibers: dysferlin,
annexin A1, TRIM 72, and PTRF (1, 41–44) (supplemental
Table S4). In addition to identifying standard integral plasma
membrane proteins like CD147 and Na,K-ATPase, many other
proteins were identified using our approach, including dystro-
phin and its associated glycoproteins, which have not been
identified in many of the earlier mass spectrometric analyses of
the totalmuscle proteomedue to their low abundance and large
FIGURE 1. Schematic illustration of detergent and mechanical lysis approaches used to isolate sarcolemmal proteome. Cultured muscle cells were
biotinylated, and the cell surface proteins were extracted either by lysing cells with detergent or by mechanical homogenization. Biotinylated cell surface
proteins were then purified by bindingwithmagnetic streptavidin beads and sequentially washingwith a high salt (50mM Tris, pH 8.0, and 150mMNaCl) and
high pH buffer (100 mM sodium carbonate, pH 11.5) to remove nonspecifically bound proteins. Detergent lysis allowed isolation of only the biotinylated
proteins,whereasmechanical lysis resulted inmembrane sheets containingbiotinylatedandnon-biotinylatedproteins embedded inor tightly associatedwith
the membrane sheet. The isolated proteins were resolved by SDS-PAGE and analyzed by LC-MS/MS after in-gel digestion with trypsin.
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molecular weight. Therefore, the membrane sheet approach
offers the sensitivity for generating a comprehensive data set for
even low abundance proteins present in the sarcolemma.
Quantitative Analysis of the Cell Surface Proteome of Myofi-
bers in Response to Injury—To identify changes in themyofiber
sarcolemmal proteome during 10 min of repair following acute
injury, we used muscle tissue from metabolically L-lysine
(13C6)-labeled mice, termed SILAM (33) or SILAC mice (32),
coupled to LC-MS/MS for protein identification and quantifi-
cation. The cell surface of the isolated fibers from heavy lysine-
labeled and unlabeled mice were biotinylated as described
before, except this time we used the intact myofibers obtained
from EDL and soleus muscles of mice fed with normal (12C6)
L-lysine and heavy (13C6) L-lysine. Fibers from the heavy or light
lysine-labeled mice were injured by passage through a narrow
bore pipette. In independent experiments, we tested the extent
of injury and the healing ability of EDL and soleusmuscle fibers
following mechanical injury by the ability of the fibers to
exclude FM1-43 dye,whose fluorescence increases significantly
upon entering injured myofiber and binding the intracellular
membrane (supplemental Fig. 2) (1). Fibers that heal will man-
age to exclude this dye. We found that this approach of myofi-
ber injury resulted in injury of50% of fibers, and77% of the
injured fibers healed within the 10 min at 37 °C. Fig. 3C shows
the morphology of the myofibers prior to and immediately fol-
lowing the injury of EDL muscle.
For proteomic analysis, the injury-triggered alteration in the
cell surface level of proteins was quantified in four independent
muscle pairs; in two pairs, SILAC-labeledmuscles were injured,
FIGURE 2. Pie charts showing the subcellular localization of proteins. Shown are proteins identified in the cell surface proteome of C2C12 myoblasts
processed using the detergent solubilization approach (A) and from C2C12 (B) and H2K (C) myoblasts using the mechanical lysis approach. Each protein was
designated only one subcellular location, and the number of proteins in each compartment has been represented as a percentage of total proteins identified.
The subcellular location of the identified proteins was determined by the Gene Ontology database (see the UniprotWeb site) as well as literature search. Data
used to construct these pie charts are presented in supplemental Tables S1–S4, which also detail the information on all of the proteins identified in two
independent biological replicates, including the percentage of coverage and number of peptide hits.
TABLE 1
Comparison of sarcolemma-associated proteins identified from
C2C12 cells using the mechanical lysis approach in four independent
biological replicates (experiments E1–E4)
Subcellular localization of identified proteins was determined according to a Uni-
prot Gene Ontology database and literature search. Each protein was designated
with only one subcellular location, and the number of proteins in each compartment
has been represented as the percentage of total proteins identified.
E-1 E-2 E-3 E-4 Average
% % % % %
Membrane 46 46 47 51 47 2
Secreted 3 5 3 3 3 1
Cytoskeleton 10 10 11 9 10 1
Nucleocytoplasmic 30 25 27 26 27 2
Organelle 10 13 10 9 10 2
Unclassified 2 1 2 2 2 0
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whereas unlabeled muscles were not injured, and in the other
two, unlabeled muscles were injured and SILAC-labeled mus-
cles were not injured. Injured fibers were allowed to heal for 10
min in the presence of 2mMcalcium.At this point, allmyofibers
from the heavy lysine-labeled and unlabeled muscle were
pooled together and processed as before to isolate the cell sur-
face proteome. Using this approach, we were able to identify
and quantitate 493 protein pairs.
For all peptides detected in any experiment, the ratio of
labeled and unlabeled peptide pairs was determined from the
extracted ion chromatogram for heavy and light peptide with a
regression correlation of98%. In each experiment, the ratio of
labeled to unlabeled protein and the S.D. value of this ratiowere
calculated by averaging ratios for the individual peptides corre-
sponding to that protein. This value was also used to carry out
one sample t test for each experiment, which identified 320
protein pairs that were significantly (p value 0.05) different
from a value of 1 (no change). By curating this list further for
proteins that were detected in at least three of the four muscle
pairs analyzed, we identified 110 proteins with altered protein
expression. The -fold change (ratio of injured versus uninjured)
obtained from these independent experimentswas used to rank
the proteins. Table 2 lists 25 proteinswhose sarcolemmal abun-
dance increased the most in response to myofiber injury. The
subcellular localization for each of these proteins was deter-
mined based on gene ontology annotation.
In agreement with previous reports regarding TRIM72/
MG53 accumulation at the site of myofiber injury (42), we did
find in two experiments an increase in the level of this protein at
the injured sarcolemma; however, this result did not pass our
statistical filtering criteria described above. The level of the
protein PTRF, which anchors MG53 (43), was found to be
decreased at the injured sarcolemma in the only experiment it
was detected in. Interestingly, most (21 of 25) proteins that
showed the greatest increase following injury are mitochon-
drial proteins, including the mitochondrial matrix proteins
(Table 2). The presence of matrix proteins indicated that the
increase may be due to accumulation and tighter association
(not fusion) of themitochondria to the sarcolemma. Previously,
electron microscopic analysis of muscles several hours after
cold or chemical injury showed an increased number of mito-
chondria at the site of injury (3). This increase could occur due
to accumulation of the existing mitochondria at the site of the
injury or due to new mitochondria synthesis at the site of the
injury. Our proteomics data showed that the increased number
of mitochondrial proteins in the sarcolemmal preparation
FIGURE 3. Sarcolemmal proteomics of healthy and injuredmyofibers. A, experimental work flow for isolation of the sarcolemmal proteome from isolated
muscle fibers. B, pie chart showing the subcellular localization of all proteins identified, which was determined as described in the legend to Fig. 1. Supple-
mental Table S4 provides the complete list of proteins identified and used in making the pie chart. C, transmitted light images showing a portion of the EDL
muscle that has been mildly disaggregated and left uninjured or mechanically injured as described under “Experimental Procedures.”
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could be detected within minutes of injury, which is too soon
for new mitochondrial synthesis and argues against mitochon-
drial biosynthesis as the basis for this increased accumulation.
To test if myofiber injury causedmitochondria to rapidly move
to and accumulate at the site of injury, we processed the EDL
tissue as described for cell surface biotinylation, with the mod-
ification that instead of biotin the tissues were incubated for 10
minwith theMitoTracker dye, and the fibers were then imaged
live at 37 °C in injured or uninjuredmyofibers. Uninjuredmyo-
fibers exhibited striated distribution throughout the length of
the myofiber (fiber 1 in Fig. 4A). However, in injured fibers
(fiber 2 in Fig. 4A), the mitochondrial labeling was increased at
the site of injury (judged by the point of fiber contraction).
Because this approach is not feasible for real-time visualization
of mitochondrial dynamics during the course of myofiber
injury, we attempted to visualize mitochondrial dynamics by
laser-induced injury of individual myofibers. Using FM1-43
dye, we first established the ability to injure myofibers isolated
from EDL and soleus muscles such that they can successfully
heal from injury (supplemental Fig. 2). Next, using this same
approach, wemonitored the response ofmitochondria to laser-
induced myofiber injury. For this, we labeled myofibers, as
above, with MitoTracker dye. The fibers were washed free of
the dye and imaged in real time prior to injury and as they were
injured using a pulsed laser. In 70% of the injured myofibers,
mitochondria were found to accumulate at the site of the injury
in a manner directly dependent on the extent of the injury;
minor injury causes lower andmajor injury causes higher accu-
mulation of mitochondria (Fig. 4, B and C and supplemental
Movie 1). Accumulation of mitochondria at the site of the
injury occurred within seconds of the injury, and repeated
injury at the same site resulted in cumulative increase of mito-
chondria at the site of the injury with each injury (Fig. 4D,
Region 1). At the site proximal to the site of injury, there was
continuous decrease in mitochondrial staining during the
course of imaging (Fig. 4D, Region 2). These observations indi-
cate that the myofiber injury-induced increase in mitochon-
drial proteins at the sarcolemma is due to rapid (within
seconds) accumulation of mitochondria to the injured sarco-
lemma from regions proximal to the site of the injury. The
MitoTracker dye used in these experiments would diffuse out
of the mitochondria if the mitochondria were to lose integrity,
causing a loss in dye signal. The finding that the increase in dye
signal we detect is sustained (Fig. 4D and supplemental Movie
1) suggests that the mitochondria accumulating at the sites of
injury are not losing their function. These observations suggest
that the mitochondria translocate to the site of myofiber injury
and become tightly associated with the injured sarcolemma,
resulting in an increase inmitochondrial protein as identified in
our proteomics experiments.
In a similar analysis of the effect of cell injury on cytosolic
proteins that appear at the cell surface in C2C12 myoblasts,
seven proteins were identified, none of which were mitochon-
drial proteins (45). This observation was confirmed by our sim-
ilar analysis of cultured C2C12 myoblasts.4 These results sug-
gest that the mitochondrial translocation to the injured
sarcolemma may be specific to myofibers. To test this, we
4 N. Sharma, S. Medikayala, K. J. Brown, Y. Hathout, and J. K. Jaiswal, unpub-
lished observations.
TABLE 2
Proteins whose abundance at the sarcolemma increased in injured muscles
Injury-triggered alteration in the level of cell surface proteins was quantified in four biological replicates (experiments E1–E4). In each experiment, -fold change for
individual protein and the S.D. value were calculated by averaging the ratio of labeled and unlabeled peptide pairs detected for that protein. Each labeled and unlabeled
peptide ratio was determined from the extracted ion chromatogram for heavy and light peptide with a regression correlation of98%. We used one sample t test for each
experiment to identify proteins that were significantly (p 0.05) different from a value of 1 (no change). Of these proteins, the top 25 that are present in at least three of the
four replicate experiments are shown here. The average -fold change obtained from these independent experiments was used to rank the proteins. The subcellular
localization for each protein, based on gene ontology annotation, shows an abundance of mitochondrial proteins.
Accession Description
Change (injured/uninjured)
Subcellular locationE-1 E-2 E-3 E-4 Average
-fold
P05202 Aspartate aminotransferase 1.77 1.32 1.99 1.69 Mitochondrion matrix
P08249 Malate dehydrogenase 1.61 1.31 2.48 1.02 1.60 Mitochondrion matrix
P51174 Long chain-specific acyl-CoA dehydrogenase 1.79 1.52 1.86 1.04 1.55 Mitochondrion matrix
P97807 Fumarate hydratase 1.39 1.92 1.08 1.46 Mitochondrion
P54071 Isocitrate dehydrogenase (NADP) 2.12 0.80 1.57 1.31 1.45 Mitochondrion
P42125 3,2-trans-Enoyl-CoA isomerase 1.62 1.18 1.94 0.93 1.42 Mitochondrion matrix
Q8BH95 Enoyl-CoA hydratase 1.43 1.43 1.33 1.40 Mitochondrion matrix
Q99KI0 Aconitate hydratase 1.49 1.33 1.57 1.08 1.37 Mitochondrion
Q91WD5 NADH dehydrogenase (ubiquinone) iron-sulfur protein 2 1.18 1.52 1.37 1.36 Mitochondrion inner membrane
Q60597 2-Oxoglutarate dehydrogenase E1 component 1.12 1.40 1.51 1.34 Mitochondrion matrix
O08749 Dihydrolipoyl dehydrogenase 1.29 1.30 1.59 1.07 1.31 Mitochondrion matrix
P47934 Carnitine O-acetyltransferase 1.47 1.40 1.27 1.08 1.31 Endoplasmic reticulum
Q9D6R2 Isocitrate dehydrogenase (NAD) subunit  1.47 1.33 1.09 1.30 Mitochondrion
Q9CZU6 Citrate synthase 1.38 1.33 1.40 1.06 1.29 Mitochondrion matrix
Q8QZT1 Acetyl-CoA acetyltransferase 1.67 1.09 1.33 1.07 1.29 Mitochondrion
P31001 Desmin 1.76 0.93 1.06 1.25 Cytoplasm
Q91VD9 NADH-ubiquinone oxidoreductase 75-kDa subunit 1.20 1.59 0.95 1.24 Mitochondrion inner membrane
P82348 -Sarcoglycan 1.99 0.61 1.09 1.23 Cell membrane
Q91YT0 NADH dehydrogenase (ubiquinone) flavoprotein 1 1.17 1.50 0.98 1.21 Mitochondrion inner membrane
Q8BKZ9 Pyruvate dehydrogenase protein X component 1.05 1.22 1.37 1.21 Mitochondrion matrix
Q91Z83 Myosin-7 1.39 0.64 1.59 1.16 1.20 Cytoplasm (myofibril)
P47738 Aldehyde dehydrogenase 1.05 1.08 1.29 1.33 1.19 Mitochondrion matrix
Q9CZ13 Cytochrome b-c1 complex subunit 1 1.17 1.45 0.91 1.18 Mitochondrion inner membrane
Q9D0M3 Cytochrome c1, heme protein 1.23 1.45 0.81 1.16 Mitochondrion inner membrane
Q99LC3 NADH dehydrogenase (ubiquinone) 1  subcomplex subunit 10 1.11 1.46 0.91 1.16 Mitochondrion matrix
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labeled the C2C12 myoblasts (data not shown) and myotubes
(Fig. 4E) with the MitoTracker dye and carried out localized
laser injury on these cells. Following laser injury, mitochondrial
translocation to the site of injury was not observed. Instead,
mitochondria remained at the same location as before. The
only change that was commonly observed was a loss in mito-
chondrial potential leading to the loss of MitoTracker from the
mitochondria in the injured myoblasts. Similar results were
also observed even in the case of primary mouse myoblasts
(data not shown).
To examine if the accumulation of functional mitochon-
dria is involved in the process of healing the injured myofi-
ber, we reasoned that blocking mitochondrial function
should impact the ability of the injured myofibers to heal.
For this, we acutely treated the myofibers with varying con-
centrations of the mitochondrial uncoupler, CCCP. Treat-
ment of myofibers with 5 or 10 M CCCP for 30 min did not
compromise the viability of the myofibers, as judged by the
entry of FM1-43 into the myofiber (Fig. 5B, Preinjury); how-
ever, if during this period the fibers were injured by a pulsed
FIGURE 4. Effect of myofiber injury on mitochondrial distribution. A, MitoTracker Red (CM-H2XRos)-labeled EDL muscle was loosely dissociated with
collagenase and mechanically injured as described under “Experimental Procedures.” Shown are the transmitted light image (left) and MitoTracker staining
(right) of uninjured (1) and injured (2) myofibers 10 min following mechanical injury. B, myofibers were labeled with MitoTracker, and the excess dye was
washed multiple times. The fibers were then injured using a high intensity pulsed laser, and the images show independent fibers before (left) and 50 s after
(right) injury. B, mild injury; C, severe injury; the injury sites are marked by the arrows. D, plot showing MitoTracker intensity at the site of injury (Region 1) and
an adjacent region (Region 2) for a fiber that wasmildly injured five times (arrows). Due to the use of a high intensity laser for the injury, each injury resulted in
quenching of the fluorescence of the mitochondria present at the wound site prior to injury, the recovery of this fluorescence to higher than preinjury value
suggesting accumulationof newmitochondria because theMitoTracker used for labelingwas removedbymultiplewashes. The inset shows an enlarged image
of the fiber at the start of imaging (0 s) andvarious time intervals postinjuries.Note theaccumulationof themitochondria at the siteof injury (Region1),whereas
a site adjacent to the injury (Region 2) shows decreasedmitochondrial fluorescence. E, C2C12myotubeswere labeledwithMitoTracker, and following removal
of excess dye, themyotubewas injuredmultiple times using apulsed laser and imaged at 2-s intervals. Amyotubebefore (left) and 100 s after (right) laser injury
is shown. The arrowmarks the site of injury, and the boxmarks the regionwhere theMitoTracker intensitywasmeasured. F, plot showingMitoTracker intensity
(arbitraryunits (a.u.)) at the siteof injury.Witheachof the four injuries (arrows), themyotubehealed (indicatedby lackofhypercontraction), but theMitoTracker
staining intensity decreased irreversibly with each injury. Loss of MitoTracker staining occurred even for mitochondria distal from the site of injury.
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laser, the healing of the fiber was compromised in a CCCP
concentration-dependent manner (Fig. 5, B and C). Fibers
that were injured similarly but were not treated with CCCP
were capable of healing in a calcium-dependent manner (Fig.
5, A and C, and supplemental Fig. 2).
DISCUSSION
Several proteomic comparisons of whole skeletal muscle
tissue have been reported (10–13). However, the sarcolem-
mal proteome is poorly characterized because proteomic
profiling of the sarcolemma remains challenging due to the
low abundance of these proteins as compared with other
proteins in muscle. In this study, we have established an
improved proteomic approach to study sarcolemmal and
associated proteome of cultured muscle cells as well as tis-
sue. Although cultured muscle cells are useful in studying
various aspects of skeletal muscle biology, as highlighted by
this and other studies, the information obtained from the
skeletal muscle tissue, either individual fibers or whole mus-
cle, is physiologically more relevant. Therefore, there is a
need to develop approaches that allow study of the sarco-
lemma from both of these sources, namely cells in culture
and myofibers. An earlier report of isolated C2C12 myoblast
cell surface proteome, using membrane fractions obtained
by centrifugal isolation, identified 213 protein spots on a
two-dimensional gel and 653 unique spots in total cell lysate,
resulting in membrane protein enrichment of 33% (14). In
comparison, our membrane sheet enrichment strategy
resulted in the identification of 53% membrane proteins in
cell culture and 33% membrane proteins from myofibers.
Another such study used oligosaccharide-based labeling of
cell surface proteins and identified 128 cell surface N-linked
glycoproteins in C2C12 cells (16). Use of our approach in
C2C12 cells enabled identification of 168 integral sarcolem-
mal membrane proteins and 284 sarcolemma-associated
proteins. Thus, compared with the existing approaches, our
approach for isolating plasma membrane sheets offers
improved coverage of the sarcolemmal proteome. Some of
the proteins we obtained were classified in the GO database
to be localized to subcellular locations other than plasma
membrane. This is due to multiple localizations of some pro-
teins (e.g. endoplasmic reticulum-resident proteins GRP78/
BiP and protein-disulfide isomerase are also present at the
plasma membrane) (46, 47). Similarly, elongation factor-1,
FIGURE 5. Effect of inhibitingmitochondrial function onmyofiber healing.Myofibers isolated from EDLmuscle were injured using a high intensity pulsed
laser in the presence of 2 M FM1-43 dye. The myofibers were either not treated (A) or treated with 10 M CCCP for 30 min prior to injury (B). C, plot showing
the kinetics of increase in FM1-43 intensity (arbitrary units (a.u.)) following injury averaged for up to 10 myofibers in each condition. The error bars define the
S.E. in the signal at each time point.
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which has a well established role in protein synthesis in the
cytoplasm, also has a role in cytoskeletal reorganization (48).
Use of the membrane enrichment strategy to isolate the cell
surface proteome of myofibers identified many low abundance
sarcolemmal proteins implicated in muscle diseases, including
dysferlin, myotilin, dystrophin, and its associated membrane
glycoproteins (-sarcoglycan, -sarcoglycan, -sarcoglycan,
and -syntrophin). Many of these proteins have not been iden-
tified earlier in themass spectrometric analysis of the totalmus-
cle proteome (49). A more recent study reported the use of
direct on-membrane digestion of one-dimensional blots of a
sarcolemma-enriched fraction isolated from the hind leg mus-
cle homogenate by subcellular fractionation followed by the
lectin agglutination technique (19). Mass spectrometric analy-
sis of the proteins obtained after on-membrane digestion
identified only 16 proteins, including dysferlin, dystrophin,
-syntrophin, ryanodine receptor, myosin heavy chain, calci-
um-transporting ATPase, aldolase, and mitochondrial F1-AT-
Pase. Our membrane sheet enrichment protocol reported in
this study utilized smaller muscles (EDL and soleus in place of
gastrocnemius) and still identified more sarcolemmal mem-
brane proteins (59 proteins) in the muscle fiber preparations.
This included not only those proteins identified by Lewis and
Ohlendieck (19) but several additional proteins, such as -sar-
coglycan, -sarcoglycan, sarcolemma-associated protein, cad-
herin, and sodium-potassiumATPase. Moreover, proteins that
only had a single peptide hit in this study (19), like -sarcogly-
can andmuscle creatine kinase, were also better represented in
the proteomic profile obtained in our study because more pep-
tide hits were obtained for each protein (supplemental Table
S4). These findings demonstrate the utility of our plasmamem-
brane proteome isolation approach in the analysis of small tis-
sue samples, making it a potentially valuable tool in gaining
insights into sarcolemmal proteome changes associated with
normal and pathophysiological conditions.
Quantitative proteomics using SILAC provides a useful and
powerful strategy to investigate the global changes in the levels
of individual proteins in a biological sample. Use of our pro-
teomics approach for monitoring sarcolemma-associated pro-
teins in resting myofibers identified a large number of mito-
chondrial proteins (20% of total proteins) that belonged to
inner or outer mitochondrial membrane as well as mitochon-
drialmatrix (supplemental Table S4). This suggests that there is
a tight association of mitochondria with the sarcolemma.
Unlikemyofibers, a similar analysis of C2C12 sarcolemmal pro-
teome using this approach showed that 7% mitochondrial
proteins are associatedwith the sarcolemmal proteome.4Other
organelles tightly associated with the myofiber sarcolemma
include the endoplasmic reticulum and endosomes.
Using the proteomic approach described here together with
in vivo stable isotope labeling of proteins, we quantitatively
compared the differences between the myofiber sarcolemma-
associated proteome from uninjured versus acutely injured
myofibers following 10min of healing. Although small changes
in the level of proteins previously implicated in myofiber repair
MG53 and PTRF were detected, the largest and statistically
significant increase was observed for mitochondrial proteins.
This finding, although unexpected, is not unprecedented
because accumulation of mitochondria at the site of myofiber
injury has previously been observed by an EM-based analysis of
acute muscle injury in vivo (3).
Our results indicated that injury may be causing a rapid and
robust sarcolemmal association of mitochondria, which was
confirmed by live imaging of injured myofibers. Interestingly,
this response of mitochondria is limited to the myofibers and
does not occur in myoblasts and myotubes. The latter observa-
tion is in agreement with a recent study using C2C12myoblasts
in culture, which reported that seven proteins, including cyto-
skeleton, endoplasmic reticulum, and nuclear proteins, are
exposed on the surface of cultured cells following mechanical
injury (45). The selective accumulation of active mitochondria
at the site of injury and tight association with the injured myo-
fiber sarcolemmal membrane raises questions regarding the
potential functional role of this process. A dose-dependent
decrease in the kinetics of healing of the injured myofibers by
mitochondrial uncoupler CCCP provides evidence that mito-
chondrial function is required for the healing of the injured
myofibers. Treatment with 10MCCCP inhibited the ability of
the injured myofibers to heal and also affected the ability of
some of the treatedmyofibers to undergo contracture (Fig. 5B).
Therefore, mitochondrial accumulation has a functional role in
the healing of the injured myofiber. In the EM study by Papad-
imitriou et al. (3), it was noted that the injured myofiber heals
the site of the injury without the formation of a new sarco-
lemma. If so, accumulating mitochondria could function as
“sandbags” soaking up the flood of extracellular calciumby rap-
idly sequestering it. Additionally, they could also be providing
the barrier function against inflow of other extracellular fluids
while the myofibers build the new sarcolemma. Moreover,
because repair of injured cell requires a variety of energy-de-
pendent processes (50, 51), the presence of a rich supply of
active mitochondria would also meet the local energy demand
for healing of the injured sarcolemma.Mitochondria have been
reported to associate with sarcolemma during myogenesis,
where it providesOXPHOSproteins to the sarcolemma (52). In
view of the functional role of mitochondria in myofiber repair,
it is plausible thatmitochondrialmyopathies and other diseases
associated with mitochondrial dysfunction could have an asso-
ciated myofiber repair deficit. Indeed, subsarcolemmal accu-
mulation of mitochondria is a distinguishing feature of mito-
chondrial myopathy, and these patients suffer from poor
tolerance to exercise (53). Antioxidants, which are useful in the
treatment of mitochondrial myopathy (53), have recently been
reported to aid in the healing of injured myofibers (54).
Although further studies are needed to identify the mechanism
and role(s) ofmitochondria at the site of sarcolemma injury and
the relevance of this process inmuscle diseases, our study high-
lights a previously unrecognized function of mitochondria in
muscles.
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